Superior Mesenteric Artery Syndrome With Nutcracker Phenomenon in an Ulcerative Colitis Patient: A Case Report and Literature Review Authors: Abdulla Alabed, Mohamed Wael, Mariam Adnan, Mohamed Alabbasi, Nawara Aljasim, Sara Altamimi, Faisal Abubaker, Omar Sharif Published: 2026 ABSTRACT Superior mesenteric artery syndrome (SMAS) and nutcracker phenomenon or syndrome (if with symptoms) are rare conditions. The former is caused by the compression of the third part of the duodenum between the aorta and the superior mesenteric artery (SMA), leading to duodenal obstruction, while the latter is caused by the compression of the left renal vein between the SMA and the aorta, leading to distal dilation of the vein. Coexistence of both conditions is extremely rare, and up to 2017, only 8 cases were reported. Upon literature review, a few case reports linked either SMAS or the nutcracker phenomenon with Crohn’s disease. To the best of our knowledge, no ulcerative colitis case diagnosed concurrently with SMAS or nutcracker syndrome was found. We report the case of a 20-year-old woman with active ulcerative colitis who presented with a flare-up as well as weight loss, nausea, and vomiting. In addition to her active ulcerative colitis, she was found to have concurrent SMAS and the nutcracker phenomenon upon radiological investigations. SMAS and the nutcracker phenomenon are extremely rare to occur concurrently. Management of such cases can be challenging and ranges from nutritional support to surgical interventions. Background Superior mesenteric artery syndrome (SMAS) is caused by compression of the third part of duodenum between the aorta and the superior mesenteric artery (SMA), which leads to duodenal obstruction.1 It was first described on autopsy in 1861 by Carl Freiherr von Rokitansky.1 Several years later, Wilkie in 1927 provided a detailed description of the clinical significance of this condition.2 On the other hand, nutcracker phenomenon (NCP) was first described radiologically by De Schepper in 1972.3 It is a rare condition that leads to compression of the left renal vein (LRV) between the aorta and the SMA accompanied with distal dilatation of the vein. Historically, entrapment of the LRV was described anatomically by Grant in 1937.4 Although SMAS and NCP are considered rare conditions and furthermore, their coexistence at the same time is extremely rare.5 We report a case of combined SMAS and NCP in a patient with ulcerative colitis (UC). Case Presentation We report a case of a 20-year-old woman who was diagnosed with UC 4 years prior to presentation. Her latest colonoscopy done 1 month prior to presentation in another institute revealed extensive UC involving the entire colon. She presented to our institute with a 5-day history of worsening bloody diarrhea of around 10 bowel movements per day associated with nausea and vomiting. She added that she was having loss of appetite and had lost weight over the preceding few months prior to presentation, reaching a weight of 42 kg from a baseline of 48 kg, and she was malnourished. This was accompanied with intermittent left-sided abdominal pain for 2 months. She did not complain of any flank pain or hematuria. The patient was taking mesalamine (2.4g/day) and azathioprine (100 mg/day) for her UC but her symptoms were poorly controlled. She was first diagnosed with UC in 2016, extensive disease, and was started on mesalamine and azathioprine. A follow-up colonoscopy was done at the time and showed endoscopic and histological remission. However, starting in 2019, she developed multiple relapses and flare-ups, which required frequent courses of prednisone (40 mg/day) leading to debilitating symptoms and weight loss after which she presented to our institute. The patient did not smoke or consume alcohol. On physical examination, the patient was awake, conscious, and alert. Her heart rate was 105 beats per minute, and her blood pressure was 105/50 mmHg. She was maintaining saturation on room air, and was afebrile. The patient also looked underweight. Her abdominal examination was remarkable for generalized abdominal tenderness with no significant distention. Other clinical examination was unremarkable. Her laboratory parameters including white blood cells, platelets, renal function, sodium, and liver function tests were unremarkable (Table 1). Potassium, albumin, and hemoglobin were low (Table 1). Her other laboratory values are also illustrated in Table 1. Fecal calprotectin was positive at 332.10 mg/K while her inflammatory markers erythrocyte sedimentation rate and C-reactive protein were elevated as well (Table 1). Stool analysis and culture including Gastro-Intestinal Filmarray panel & Clostridium difficile polymerase chain reaction were all negative. Her Truelove and Witss Severity Index for UC showed severe UC. Urine analysis was also done and was negative for red blood cells, protein, and white blood cells. Colonoscopy showed severe extensive UC with a Mayo score of 3 which indicates severe disease. Rectal biopsy showed active phase of ulcerative proctitis, and cytomegalovirus was not detected. Anti-cytomegalovirus antibodies were negative. An abdominal X-ray revealed dilated bowel loops with no significant air-fluid levels.Table 1Laboratory Parameters of the Patient Upon PresentationLabs resultsValueWhite blood cells8.47 × 109/LHemoglobin11.1 g/dlMean corpuscular volume71%Platelets190 × 109/LCreatinine37 μmol/LUrea1 mmol/LSodium141 mmol/LPotassium3.3 mmol/LAlbumin24.5 g/LAlanine aminotransferase17 U/LAspartate aminotransferase17 U/LAlkaline phosphatase59 U/LG-glutamyltransferase25 U/LTotal bilirubin9 μmol/LInternational normalized ratio1.27Ferritin52 ng/mLIron1.9 μmol/LTransferrin saturation5.1%Erythrocyte sedimentation rate (ESR)97 mm/hC-reactive protein (CRP)74.3 mg/L Table 1Laboratory Parameters of the Patient Upon PresentationLabs resultsValueWhite blood cells8.47 × 109/LHemoglobin11.1 g/dlMean corpuscular volume71%Platelets190 × 109/LCreatinine37 μmol/LUrea1 mmol/LSodium141 mmol/LPotassium3.3 mmol/LAlbumin24.5 g/LAlanine aminotransferase17 U/LAspartate aminotransferase17 U/LAlkaline phosphatase59 U/LG-glutamyltransferase25 U/LTotal bilirubin9 μmol/LInternational normalized ratio1.27Ferritin52 ng/mLIron1.9 μmol/LTransferrin saturation5.1%Erythrocyte sedimentation rate (ESR)97 mm/hC-reactive protein (CRP)74.3 mg/L Laboratory Parameters of the Patient Upon Presentation The patient was started on methylprednisolone 60 mg once daily intravenously on the same day of admission. On day 4 of the admission, the patient remained symptomatic. Computed tomography (CT) of the abdomen with intravenous and oral contrast was conducted to rule out intestinal obstruction. It revealed diffuse circumferential mural wall thickening involving the whole colonic segments starting from the rectum until the ascending colon with granular appearance of the surface of the bowel and loss of colonic haustration up to the distal two-thirds of the transverse colon with significant luminal narrowing. In addition, there was marked reduction of the aortomesenteric angle and aortomesenteric distance values of 19.8° and 3.7 mm, respectively (Figure 1). The LRV was also compressed in-between the aorta and proximal segment of SMA, indicating anterior NCP (Figure 2). Significant prominent and congestion of the mesenteric vessels as well as pelvic vessels were also noted.Figure 1Sagittal section of CT abdomen with contrast showing compression of the duodenum between the superior mesenteric artery and the abdominal aorta with aortomesenteric distance of 3.7 mm. Aortomesenteric angle measurement was 19.8°.Figure 2Coronal section of the CT scan of the abdomen with contrast showing compression of the left renal vein (yellow arrow). Sagittal section of CT abdomen with contrast showing compression of the duodenum between the superior mesenteric artery and the abdominal aorta with aortomesenteric distance of 3.7 mm. Aortomesenteric angle measurement was 19.8°. Coronal section of the CT scan of the abdomen with contrast showing compression of the left renal vein (yellow arrow). These findings were consistent with active colitis in conjunction with SMAS and the associated nutcracker phenomenon. On day 5 of admission, given that the patient was still having bloody diarrhea, passing 11 bowel movements per day, which is indicative of active severe UC with a repeat C-reactive protein of 119 mg/L, infliximab at a dose of 5 mg/kg was initiated as per standard regimen. Barium follow through did not show obstruction of the duodenum. She was managed conservatively with optimization of the nutritional status and cognitive behavioral therapy. As the patient had suboptimal response to infliximab (after 4 months of therapy was still found to have severe colitis) she was switched to vedalozimab (dose of 300 mg) in addition to azathioprine which was continued. She received 4 doses to date at week 0, 2, 6, and 14 of starting treatment. She showed a dramatic improvement with the biological therapy and nutritional support. Three months later, she was in clinical remission and had regained weight to 52 kg. Figure 3 shows the patient’s Truelove and Witts Severity index for UC since diagnosis and the response to treatment given. The patient continues to follow with the Gastroenterology Outpatient Clinics and is happy with the outcome achieved.Figure 3The patient’s Truelove and Witts Severity index for UC since diagnosis and the response to treatments given. The patient’s Truelove and Witts Severity index for UC since diagnosis and the response to treatments given. Discussion NCP is a rare condition that is often detected incidentally on imaging studies.6,7 The exact pathophysiology remains incompletely understood; however, it is hypothesized that the LRV becomes compressed due to reduction in the surrounding retroperitoneal fat, posterior displacement of the kidney, and anatomical variations such as abnormal branching of the SMA.8 Two main variants of NCP exist: anterior and posterior. The anterior type, which is more common, involves compression of the LRV between the abdominal aorta and the SMA,9 whereas the posterior type occurs when the LRV is compressed between the aorta and the vertebral body.10 Although the terms NCS and NCP are often used interchangeably, NCS specifically refers to symptomatic cases, which are relatively uncommon compared with asymptomatic NCP.11 Clinical manifestations of NCS vary widely, ranging from microscopic hematuria to gross hematuria, orthostatic proteinuria, flank pain, abdominal pain, varicocele, dyspareunia, dysmenorrhea, fatigue, and orthostatic intolerance.12 Diagnosis is based on clinical suspicion supported by imaging modalities such as Doppler ultrasound, CT, magnetic resonance imaging, venography, and intravascular ultrasound, after excluding other causes.13 Conservative management is recommended in mild cases,14 while persistent or severe symptoms may require interventions such as LRV stenting, transposition, or renal autotransplantation.9,15 Similarly, SMAS results from compression of the third portion of the duodenum due to narrowing of the aortomesenteric angle.16 Clinical features include postprandial epigastric pain, nausea, early satiety, bilious vomiting, anorexia, and weight loss.17 In our patient, these symptoms overlapped with those of UC, making the diagnosis particularly challenging. Radiological findings demonstrated a reduced aortomesenteric angle of 19.8° and a distance of 3.7 mm, supporting the diagnosis of SMAS.18 SMAS may be congenital or acquired, with up to 40% of cases considered idiopathic.19 A congenitally short ligament of Treitz may predispose to SMAS.20 Predisposing factors include conditions associated with loss of retroperitoneal fat, such as bariatric surgery, trauma, burns, malignancy, malabsorption, and eating disorders.21 Additional associations include aortic aneurysm repair, corrective spinal surgery for scoliosis, acquired immune deficiency syndrome, and malignancy.22,23 SMAS can also occur in children and adolescents.24,25 Management of SMAS initially involves conservative measures, including nutritional support, weight restoration, and postural therapy.26 Enteral feeding via a nasojejunal tube distal to the site of obstruction may be required when oral intake is inadequate.25 If conservative measures fail, surgical options include Strong’s procedure, duodenojejunostomy, and anterior transposition of the third part of the duodenum.22 Psychosocial support is also an important aspect of management.22 Our patient responded well to conservative management with nutritional rehabilitation and optimization of UC treatment. Low body mass index and weight loss are well-recognized risk factors for both SMAS and NCP.27,28 However, body mass index may not accurately reflect visceral fat distribution, particularly in inflammatory bowel disease (IBD), where inflammatory processes can alter body composition.29 This may partly explain the rarity of these conditions in patients with IBD. Although SMAS and NCP share a common pathophysiological mechanism involving narrowing of the aortomesenteric angle, their coexistence is exceedingly rare. A literature review identified only eight reported cases up to 2017; none were associated with IBD, and management was mainly supportive except in one case.5 Table 2 compares these previously reported cases with our case. Among patients with IBD, only a few cases of SMAS have been reported in Crohn’s disease,30, 31, 32 and a single case of NCS has been reported in nonactive Crohn’s disease.33 To our knowledge, no prior case has described the coexistence of SMAS and NCP in a patient with UC. Current literature supports the use of appropriate vascular imaging to establish the diagnosis and a conservative-first, individualized management strategy, with invasive treatment reserved for selected patients.13, 14, 15, 16,22 Overall, this case underscores the importance of considering vascular compression syndromes in patients with IBD presenting with atypical or persistent gastrointestinal symptoms. Early recognition and a multidisciplinary, patient-centered approach are essential for optimal management.Table 2Comparison of all Cases Reported up to 2017 With Our CaseYearSex/AgeComplaintsCausesHematuriaTreatment2004Male/15Abdominal pain, vomitingNoneNot availableNasogastric decompression, hydration, total peripheral nutrition (TPN)2008Female/29Vomiting, epigastric painSurgery due to brain stem gangliomaNoEnteral feeding with jejunostomy feeding tube2012Male/24Vomiting, left flank painInsulin treatment discontinuedYesNasogastric decompression, TPN, insulin2013Male/55Vomiting, epigastric pain, bloatingDietNoNot available2014Male/28Vomiting, epigastric pain, bloatingNoneNoTPN, jejunostomy feeding tube2015Female/19Epigastric pain, vomiting, anorexiaNoneNoNasogastric decompression, TPN, stocking, low molecular weight heparin2016Male/62NoneRectal carcinomaNot availableConservative treatment2017Male/23Vomiting, nausea, bloating.Physical exhaustionNoLaparoscopic duodenojejunostomy2017Female/14Abdominal pain, vomiting, nausea, gross hematuriaDietYesConservative treatment, hydrationOur caseFemale/20Nausea, vomiting, weight loss, anorexia, left abdominal pain, bloody diarrheaUlcerative colitisNoConservative treatments, biologic agents for UC. Table 2Comparison of all Cases Reported up to 2017 With Our CaseYearSex/AgeComplaintsCausesHematuriaTreatment2004Male/15Abdominal pain, vomitingNoneNot availableNasogastric decompression, hydration, total peripheral nutrition (TPN)2008Female/29Vomiting, epigastric painSurgery due to brain stem gangliomaNoEnteral feeding with jejunostomy feeding tube2012Male/24Vomiting, left flank painInsulin treatment discontinuedYesNasogastric decompression, TPN, insulin2013Male/55Vomiting, epigastric pain, bloatingDietNoNot available2014Male/28Vomiting, epigastric pain, bloatingNoneNoTPN, jejunostomy feeding tube2015Female/19Epigastric pain, vomiting, anorexiaNoneNoNasogastric decompression, TPN, stocking, low molecular weight heparin2016Male/62NoneRectal carcinomaNot availableConservative treatment2017Male/23Vomiting, nausea, bloating.Physical exhaustionNoLaparoscopic duodenojejunostomy2017Female/14Abdominal pain, vomiting, nausea, gross hematuriaDietYesConservative treatment, hydrationOur caseFemale/20Nausea, vomiting, weight loss, anorexia, left abdominal pain, bloody diarrheaUlcerative colitisNoConservative treatments, biologic agents for UC. Comparison of all Cases Reported up to 2017 With Our Case Conclusion The coexistence of SMAS and NCP represents a rare but clinically significant entity, particularly in patients with UC. This case highlights the diagnostic challenge posed by overlapping symptoms with IBD and emphasizes the importance of maintaining a high index of suspicion in patients with persistent gastrointestinal symptoms and weight loss. Early recognition through appropriate imaging and a tailored management approach can lead to favorable outcomes and prevent unnecessary escalation of IBD therapy. This case adds to the limited literature and supports the need for increased awareness of combined vascular compression syndromes in this patient population.